Also trades as: APN.JO (JNB) · $vol 13M · APNHF (OTC) · $vol 0M

$9.52

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 68 · $4.2B mcap · 367M float · 0.0002% daily turnover · Short 61% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$34.1B -21.3% ▼

5Y CAGR: -2.0%

Gross Profit

$13.8B -28.1% ▼

5Y CAGR: -5.0%

Operating Income

$5.3B +267.9% ▲

5Y CAGR: -5.7%

Net Income

$2.6B +339.3% ▲

5Y CAGR: -11.6%

EPS (Diluted)

$5.79 +337.3% ▲

5Y CAGR: -11.3%

EBITDA

$7.2B +231.5% ▲

5Y CAGR: -3.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$38.6B	$40.7B	$44.7B	$43.4B	$34.1B
YoY Growth	+2.2%	+5.4%	+9.8%	-3.0%	-21.3%
Cost of Revenue	$20.3B	$22.3B	$25.3B	$24.2B	$20.4B
Gross Profit	$18.3B	$18.4B	$19.4B	$19.1B	$13.8B
Gross Margin	47.4%	45.2%	43.4%	44.1%	40.3%
R&D Expenses	$433M	$214M	$162M	$0	$0
SG&A Expenses	$4.4B	$4.6B	$10.1B	$11.0B	$8.5B
Operating Expenses	$9.6B	$11.0B	$12.4B	$17.7B	$8.5B
Operating Income	$8.7B	$7.8B	$7.0B	$1.4B	$5.3B
Operating Margin	22.5%	19.2%	15.7%	3.3%	15.5%
Interest Expense	$765M	$1.3B	$2.2B	$1.6B	$1.5B
Income Before Tax	$8.1B	$6.6B	$5.7B	-$123M	-$409M
Tax Expense	$1.6B	$1.3B	$1.3B	$960M	$460M
Net Income	$6.5B	$5.2B	$4.4B	-$1.1B	$2.6B
Net Margin	16.8%	12.8%	9.9%	-2.5%	7.6%
EPS (Diluted)	$14.32	$11.77	$9.91	$-2.44	$5.79
EBITDA	$9.9B	$10.2B	$9.9B	$2.2B	$7.2B
Shares Outstanding	453M	444M	444M	444M	444M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$19.1B	$21.6B	$21.1B	$23.6B	$22.0B	$21.4B	$16.3B	$18.4B
Cost of Revenue	$10.2B	$11.6B	$11.8B	$13.5B	$11.5B	$12.7B	$9.2B	$11.6B
Gross Profit	$9.0B	$10.0B	$9.3B	$10.1B	$10.5B	$8.7B	$7.1B	$6.8B
Gross Margin	46.8%	46.2%	44.0%	42.9%	47.6%	40.5%	43.6%	37.1%
R&D Expenses	$0	$107M	$0	$162M	$0	$0	$0	$0
SG&A Expenses	$4.6B	$4.8B	$5.0B	$5.1B	$5.4B	$5.6B	$4.1B	$4.5B
Operating Expenses	$4.6B	$4.8B	$5.8B	$6.6B	$10.4B	$5.6B	$4.1B	$4.5B
Operating Income	$4.3B	$5.2B	$3.5B	$3.5B	$11M	$3.1B	$3.0B	$2.4B
Operating Margin	22.7%	23.9%	16.6%	14.8%	0.1%	14.3%	18.2%	12.9%
Interest Expense	$329M	$829M	$959M	$1.3B	$652M	$888M	$811M	$712M
Income Before Tax	$3.3B	$3.3B	$2.9B	$2.8B	$3.2B	-$3.3B	$1.1B	-$1.6B
Tax Expense	$624M	$703M	$594M	$716M	$797M	$163M	$275M	$187M
Net Income	$2.7B	$2.6B	$2.3B	$2.1B	$2.4B	-$3.5B	$1.4B	$1.2B
Net Margin	14.0%	11.8%	10.9%	8.9%	10.9%	-16.2%	8.6%	6.6%
EPS (Diluted)	$6.02	$5.75	$5.21	$4.71	$5.38	$-7.82	$3.15	$2.72
EBITDA	$4.8B	$5.4B	$4.4B	$5.9B	$4.9B	-$2.3B	$3.9B	$3.4B
Shares Outstanding	444M	444M	444M	444M	444M	444M	445M	444M

APNHY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet